Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy
Authors:
- Duncan F RogersDRDuncan F Rogers
- 1 February 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 10 (1) , 67-76
Abstract
Airway mucus hypersecretion is a pathophysiological feature of asthma and, in many patients, contributes to morbidity and mortality. Although current pharmacotherapy is effective in patients with stable disease, severe asthma is poorly treated, and there is no specific treatment for the hypersecretion. Consequently, identification of potential targets for pharmacotherapy of hypersecretion in asthma is warranted. This review identifies intracellular signalling pathways as rational targets for treatment of excessive airway mucus production. The inflammatory mediators and the associated intracellular signalling pathways underlying development of goblet cell hyperplasia, an index of mucus hypersecretion, are becoming ever clearer, and include T-helper type 2 (Th2) cytokines, in particular interleukin (IL)-9 and IL-13, as well as IL-1beta, tumour necrosis factor (TNF)-alpha and cyclooxygenase (COX)-2. IL-9 may act predominantly via calcium-activated chloride channels (CLCAs), IL-13 via STAT-6 and FOXA2, TNF-alpha via nuclear factor (NF)-kappaB, and IL-1beta via COX-2. Epidermal growth factor receptor (EGF-R) and FOXA2 appear to be convergent pathways for a number of mediator signals, with EGF-R up-regulated in the airways of asthmatic patients. Although many potential intracellular signalling pathways have been identified as possible targets for pharmacotherapy of airway mucus hypersecretion in asthma, the EGF-R and Th2 cytokine pathways offer the greatest potential for inhibition of excessive mucus production.Keywords
This publication has 72 references indexed in Scilit:
- Mucus hypersecretion in asthma: causes and effectsCurrent Opinion in Pulmonary Medicine, 2009
- Characterization of Side Population Cells from Human Airway EpitheliumStem Cells, 2008
- Structure and Function of the Polymeric Mucins in Airways MucusAnnual Review of Physiology, 2008
- IL-13 and Epidermal Growth Factor Receptor Have Critical but Distinct Roles in Epithelial Cell Mucin ProductionAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Treatment of airway mucus hypersecretionAnnals of Medicine, 2006
- Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and DiseasePhysiological Reviews, 2006
- PMA Induces the MUC5AC Respiratory Mucin in Human Bronchial Epithelial Cells, via PKC, EGF/TGF-α, Ras/Raf, MEK, ERK and Sp1-dependent MechanismsJournal of Molecular Biology, 2004
- Foxa2 regulates alveolarization and goblet cell hyperplasiaDevelopment, 2004
- Interleukin-9 Induces Goblet Cell Hyperplasia during Repair of Human Airway EpitheliaAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit PhosphorylationScience, 1999